Teaming with Massachusetts General Hospital and others, J&J’s Veridex is developing a novel method of isolating cancer cells from a patient’s bloodstream. If successful, the blood test could ultimately replace more invasive and…
Corporate bond sales worldwide totaled $3.19 trillion this year, as companies took advantage of the lowest yields on record.
Continue reading Corporate Bond Sales Surpass $3 Trillion on Low Yields
…
Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting — if not always positive — year. Here’s our rundown of the…
A group of J&J shareholders has filed a complaint against the company, accusing directors of ignoring warnings signs pertaining to J&J’s massive product recalls and government probes of manufacturing defects and marketing pract…
The bad news doesn’t end for Johnson & Johnson as FDA inspectors continue to find problems at the Pennsylvania plant that was the source of a massive recall of children’s medicines earlier this year.
Continue r…